According to Zhitong Finance App News, Tengsheng Pharmaceutical-B (02137) issued an announcement to issue and allocate 285,400 shares to company directors on September 21, 2026 due to restricted share unit ownership granted under the initial public offering after-sales share award scheme adopted by the company on June 22, 2021.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.